Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
19–64
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
A healthy male or female, 19 to 64 years of age (not having reached the 65th birthday) at the time of study vaccination.
You may not be if
Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine(s) within 30 days preceding administration of study vaccine, or planned use during the active phase of the study.
Chronic administration of immunosuppressants or within six months prior to administration of study vaccine.
Planned administration/ administration of a vaccine not foreseen by the study protocol within 30 days of administration of study vaccine (with the exception of an influenza vaccine).
Administration of a diphtheria-tetanus (Td) booster within previous five years.
Administration of Tdap vaccine at any time prior to study entry. History of serious allergic reaction (e.g. anaphylaxis) following any other tetanus toxoid, diphtheria toxoid or pertussis-containing vaccine or any component of the study vaccines.
Clareo Health | Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years
